Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Cochlear ( (AU:COH) ) just unveiled an announcement.
Cochlear Limited has notified the market of the issue of 617 ordinary fully paid shares following the exercise or conversion of previously unquoted options or convertible securities. The new shares, issued on 19 December 2025, represent a minor increase in the company’s equity base and reflect the ongoing utilisation of its long-term incentive or employee equity plans, with negligible immediate impact on capital structure but signalling continued alignment of management and employee interests with shareholder value.
The most recent analyst rating on (AU:COH) stock is a Hold with a A$300.00 price target. To see the full list of analyst forecasts on Cochlear stock, see the AU:COH Stock Forecast page.
More about Cochlear
Cochlear Limited is a medical device company listed on the ASX, specialising in implantable hearing solutions such as cochlear implants and related technologies for people with moderate to profound hearing loss. The company operates in the global hearing healthcare industry, targeting both adult and paediatric patients, and works closely with clinicians and hearing professionals to expand access to advanced hearing treatments.
Average Trading Volume: 128,471
Technical Sentiment Signal: Hold
Current Market Cap: A$17.06B
For a thorough assessment of COH stock, go to TipRanks’ Stock Analysis page.